title: Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice.
abstract: HCM is the most common inherited heart condition occurring in 1:500 individuals in the general population. Left ventricular outflow obstruction at rest or after provocation occurs in 2/3 of HCM patients and is a frequent cause of limiting symptoms. Pharmacologic therapy is the first-line treatment for obstruction, and should be aggressively pursued before application of invasive therapy. Beta-blockade is given first, and up-titrated to decrease resting heart rate to between 50 and 60 beats per minute. However, beta-blockade is not expected to decrease resting gradients; its effect rests on decreasing the rise in gradient that accompanies exercise. For patients who fail beta-blockade the addition of oral disopyramide in adequate dose often will decrease resting gradients and offer meaningful relief of symptoms. Disopyramide vagolytic side effects, if they occur, can be greatly mitigated by simultaneous administration of oral pyridostigmine. This combination allows adequate dosing of disopyramide to achieve therapeutic goals. Verapamil utility in obstructive HCM with high resting gradients is limited by its vasodilating effects that can, infrequently, worsen gradient and symptoms. As such, we tend to avoid it in patients with high gradients and limiting heart failure symptoms. In a head-to-head comparison of intravenous drug administration in individual obstructive HCM patients the relative efficacy for lowering gradient was disopyramide > beta-blockade > verapamil. Severe symptoms in non-obstructive HCM are caused by fibrosis or severe myocyte disarray, and often by very small LV chamber size. Severe symptoms caused by these anatomic and histologic abnormalities, in the absence of obstruction, are less amenable to current pharmacotherapy. New pharmacotherapeutic approaches to HCM are on the horizon, that are to be evaluated in formal therapeutic trials.
authors.affiliation: New York University Langone Medical Center, 530 First Avenue, NYC, NY 10016, USA. mark.sherrid@nyumc.org.
authors.forename: Mark V
authors.initials: MV
authors.lastname: Sherrid
mesh_terms: D000818:Animals; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D004206:Disopyramide / Q000627:therapeutic use; D004562:Electrocardiography; D006801:Humans; D006973:Hypertension / Q000150:complications; D014694:Ventricular Outflow Obstruction / Q000503:physiopathology
chemical_list: D004206:Disopyramide
references.citation: J Am Coll Cardiol. 2000 Jan;35(1):36-44
references.pmid: 10636256
references.citation: Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1345-51
references.pmid: 10749732
references.citation: J Am Coll Cardiol. 2000 Oct;36(4):1344-54
references.pmid: 11028493
references.citation: Circulation. 2001 Feb 13;103(6):789-91
references.pmid: 11171784
references.citation: Circulation. 2003 Jul 29;108(4):445-51
references.pmid: 12860912
references.citation: Circ Res. 2004 Jul 23;95(2):135-45
references.pmid: 15271865
references.citation: Circulation. 2004 Aug 24;110(8):904-10
references.pmid: 15302796
references.citation: Br J Pharmacol. 2005 Feb;144(3):317-22
references.pmid: 15655528
references.citation: N Engl J Med. 2005 Jan 27;352(4):362-72
references.pmid: 15673802
references.citation: J Am Coll Cardiol. 2005 Apr 19;45(8):1251-8
references.pmid: 15837258
references.citation: Heart. 2005 Jul;91(7):920-5
references.pmid: 15958362
references.citation: Circulation. 2005 Nov 22;112(21):3280-8
references.pmid: 16301359
references.citation: Circulation. 2006 Jul 18;114(3):216-25
references.pmid: 16831987
references.citation: Pharmacol Rev. 2006 Sep;58(3):521-90
references.pmid: 16968950
references.citation: Circulation. 2006 Nov 21;114(21):2232-9
references.pmid: 17088454
references.citation: Circulation. 2007 Feb 20;115(7):918-27
references.pmid: 17309938
references.citation: N Engl J Med. 2007 Mar 15;356(11):1140-51
references.pmid: 17360992
references.citation: J Am Coll Cardiol. 2007 Mar 20;49(11):1203-11
references.pmid: 17367665
references.citation: Cardiovasc Drug Rev. 2007 Spring;25(1):76-97
references.pmid: 17445089
references.citation: Circulation. 2007 Jul 24;116(4):434-48
references.pmid: 17646594
references.citation: Circulation. 2007 Oct 9;116(15):1647-52
references.pmid: 17804441
references.citation: Circulation. 2007 Dec 4;116(23):2702-8
references.pmid: 18025528
references.citation: Heart. 2008 Oct;94(10):1288-94
references.pmid: 18032461
references.citation: Circulation. 2008 Jan 22;117(3):429-39
references.pmid: 18212300
references.citation: Am J Cardiol. 2008 Feb 15;101(4):516-20
references.pmid: 18312769
references.citation: Mayo Clin Proc. 2008 Jun;83(6):630-8
references.pmid: 18533079
references.citation: J Am Coll Cardiol. 2009 Jul 14;54(3):212-9
references.pmid: 19589433
references.citation: Echocardiography. 2009 Sep;26(8):922-33
references.pmid: 19968680
references.citation: J Clin Invest. 2010 Oct;120(10):3520-9
references.pmid: 20811150
references.citation: Circulation. 2010 Oct 19;122(16):1562-9
references.pmid: 20921440
references.citation: Am J Cardiol. 2010 Nov 1;106(9):1307-12
references.pmid: 21029829
references.citation: J Am Soc Echocardiogr. 2011 Jan;24(1):75-82
references.pmid: 21126858
references.citation: Echocardiography. 2011 Oct;28(9):E174-9
references.pmid: 21801200
references.citation: Circulation. 1990 Apr;81(4):1260-70
references.pmid: 2180591
references.citation: Circulation. 2011 Dec 13;124(24):e783-831
references.pmid: 22068434
references.citation: J Am Coll Cardiol. 2011 Nov 22;58(22):2313-21
references.pmid: 22093509
references.citation: Am J Cardiol. 2012 Aug 15;110(4):568-74
references.pmid: 22591671
references.citation: Am J Cardiol. 2012 Sep 1;110(5):715-9
references.pmid: 22633205
references.citation: Prog Cardiovasc Dis. 2012 May-Jun;54(6):461-76
references.pmid: 22687587
references.citation: Prog Cardiovasc Dis. 2012 May-Jun;54(6):477-82
references.pmid: 22687588
references.citation: Prog Cardiovasc Dis. 2012 May-Jun;54(6):483-92
references.pmid: 22687589
references.citation: Eur Heart J. 2012 Jul;33(14):1724-33
references.pmid: 22719025
references.citation: Ann Thorac Surg. 2012 Dec;94(6):1990-7; discussion 1997-8
references.pmid: 22858269
references.citation: Circulation. 2013 Feb 5;127(5):575-84
references.pmid: 23271797
references.citation: Am J Cardiol. 2013 Apr 1;111(7):1040-5
references.pmid: 23340036
references.citation: J Med Genet. 2013 Apr;50(4):228-39
references.pmid: 23396983
references.citation: J Am Soc Echocardiogr. 2013 May;26(5):556-65
references.pmid: 23534983
references.citation: J Am Coll Cardiol. 2013 Jun 18;61(24):2487-2488
references.pmid: 23602772
references.citation: Heart. 2013 Dec;99(24):1800-11
references.pmid: 23674365
references.citation: Circ Heart Fail. 2013 Jul;6(4):694-702
references.pmid: 23704138
references.citation: JACC Heart Fail. 2013 Dec;1(6):480-7
references.pmid: 24621999
references.citation: Mayo Clin Proc. 2014 Jun;89(6):727-37
references.pmid: 24793961
references.citation: Eur Heart J. 2014 Oct 14;35(39):2733-79
references.pmid: 25173338
references.citation: J Am Coll Cardiol. 2014 Nov 11;64(19):1984-95
references.pmid: 25440093
references.citation: Circulation. 1989 May;79(5):1052-60
references.pmid: 2785441
references.citation: Am Heart J. 2017 May;187:145-155
references.pmid: 28454798
references.citation: Am J Cardiol. 1988 Dec 1;62(17):1252-5
references.pmid: 3057852
references.citation: Am J Cardiol. 1988 Nov 15;62(16):1085-8
references.pmid: 3189171
references.citation: J Am Coll Cardiol. 1987 Sep;10(3):633-41
references.pmid: 3624669
references.citation: J Am Coll Cardiol. 1986 Sep;8(3):545-57
references.pmid: 3745699
references.citation: Int J Cardiol. 1986 Nov;13(2):219-29
references.pmid: 3793279
references.citation: Circulation. 1968 Nov;38(5):846-58
references.pmid: 4177137
references.citation: Am J Cardiol. 1979 Jun;43(6):1086-102
references.pmid: 571670
references.citation: Circulation. 1967 May;35(5):847-51
references.pmid: 6067064
references.citation: Circulation. 1982 Aug;66(2):447-53
references.pmid: 7094252
references.citation: Circulation. 1981 Sep;64(3):437-41
references.pmid: 7196300
references.citation: N Engl J Med. 1982 Oct 14;307(16):997-9
references.pmid: 7202121
references.citation: Eur J Clin Pharmacol. 1978 Nov 27;14(3):195-201
references.pmid: 729614
references.citation: Circulation. 1995 Nov 15;92(10):2886-94
references.pmid: 7586256
references.citation: Aust N Z J Med. 1995 Apr;25(2):111-3
references.pmid: 7605290
references.citation: J Am Coll Cardiol. 1995 Sep;26(3):768-75
references.pmid: 7642872
references.citation: J Cardiovasc Pharmacol. 1995 Mar;25(3):469-72
references.pmid: 7769814
references.citation: J Clin Invest. 1993 May;91(5):2150-4
references.pmid: 8098046
references.citation: Ann Intern Med. 1993 Sep 15;119(6):466-73
references.pmid: 8102838
references.citation: J Am Coll Cardiol. 1993 Sep;22(3):816-25
references.pmid: 8354817
references.citation: J Am Coll Cardiol. 1993 Jan;21(1):182-8
references.pmid: 8417060
references.citation: Am Heart J. 1993 Jun;125(6):1691-7
references.pmid: 8498312
references.citation: Aust N Z J Psychiatry. 1997 Aug;31(4):601-3
references.pmid: 9272272
references.citation: J Am Soc Echocardiogr. 1997 Sep;10(7):707-12
references.pmid: 9339420
references.citation: Circulation. 1998 Jan 6-13;97(1):41-7
references.pmid: 9443430